AskTheDate.com
Back to calendar

Metagenomi Therapeutics, Inc. (MGX) Earnings

MGX reports earnings on Monday, August 10, 2026

earnings report
August 10, 2026 · After Market Close
Q2 2026
Est. EPS: $-0.60
Actual EPS: $-0.73
EPS surprise: -31.99%
Company overview
Market Cap$46.1M
PriceUSD 1.22
EPS (TTM)-2.49
52-week high3.95
52-week low1.13
SectorHealth Technology
IndustryPharmaceuticals: Major
Employees119